NCT04535596

Brief Summary

Knee osteoarthritis (OA) is a rheumatic disease that causes serious cartilage damage in the knee joint. Moderate physical activity can slow cartilage degeneration in moderate OA stages. Remarkable weakness and atrophy of the quadriceps and hamstrings is a common problem in patients with chronic osteoarthritis, but in arthritis, it may be difficult to achieve strength gains due to the pain caused by heavy load-resistant exercises. Exercising with these high loads may not be possible or may injure painful arthritic knees. For this reason, lately, blood flow restriction exercises have been directed to achieve the same gain by exercising with lower loads by restricting the blood flow with a cuff. We aimed to limit the blood flow in osteoarthritic knees and to provide strength gain and pain reduction provided by conventional exercises given routinely. Our hypothesis in this study is that exercises that blood flow restriction exercises will reduce pain and increase strength as well as conventional exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 2, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2022

Completed
Last Updated

March 15, 2022

Status Verified

March 1, 2022

Enrollment Period

1.4 years

First QC Date

August 28, 2020

Last Update Submit

March 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain Intensity

    Pain intensities which are assessed by visual analogue scale(VAS) divided 10 equal intervals. "0" means no pain and "10" means unbearable pain. Higher scores idicate worse pain intensity.

    12 weeks

  • WOMAC score

    score among patients with knee and/or hip osteoarthritis. The Index is self-administered, 24 question, 5-point Likert. Scores range from 0 to 96 for the total WOMAC where higher scores indicate worse function.

    12 weeks

Secondary Outcomes (8)

  • high sensitive C-reactive protein (hs-CRP)

    12 weeks

  • Physical Function

    12 weeks

  • Physical Function

    12 weeks

  • Physical Function

    12 weeks

  • Quadriceps muscle strength

    4 weeks

  • +3 more secondary outcomes

Study Arms (2)

Conventional Exercises

EXPERIMENTAL

12 week long strength training exercise with the higher loading (%70-80 of 1 Repetitive Maximum)

Other: Exercise

Blood Flof Restriction Exercises

EXPERIMENTAL

12 week long strength training exercise with the lower loading (%20-30 of 1 Repetitive Maximum) by using cuff around the thigh

Other: Exercise

Interventions

12 week long strength training exercises for knee

Blood Flof Restriction ExercisesConventional Exercises

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants between the ages of 45-70, diagnosed with knee osteoarthritis according to the criteria of the American College of Rheumatology.
  • Participants who stated that the severity of knee pain to be evaluated with Visual Analog Pain Scale (VAS) is between 2-8
  • Participants who are voluntaries for the study

You may not qualify if:

  • Participants who have patellar subluxation or dislocation around the knee, who have other sources of knee pain such as bursae, fat pad and a history of knee surgery,
  • Those who are in Grade 1 or 4 according to the Kellgren-Lawrence radiographic staging
  • Those who have participated in leg weight exercise training in the last 6 months
  • Participants who are under the high risk of venous thrombosis (lower extremity surgery, cardiovascular conditions including high blood pressure (\> 140/90) in the past 6 months),
  • Diabetes, pregnancy, unexplained chest pain or heart disease, fainting or dizziness during physical activity / exercise.
  • If exercise is contraindicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gizem Ergezen

Istanbul, Beykoz, 34810, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis, KneeArthralgiaHypertrophy

Interventions

Exercise

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gizem Ergezen, MSc

    Medipol University

    PRINCIPAL INVESTIGATOR
  • Mustafa Sahin, PhD

    Medipol University

    PRINCIPAL INVESTIGATOR
  • Candan Algun, PhD

    Medipol University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gizem Ergezen, MSc, Physiotherapist

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 2, 2020

Study Start

September 1, 2020

Primary Completion

January 10, 2022

Study Completion

February 11, 2022

Last Updated

March 15, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
starting 3 months after publication

Locations